新型β-内酰胺类抗生素对不动杆菌属的体外活性
In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.
作者信息
Garcia I, Fainstein V, LeBlanc B, Bodey G P
出版信息
Antimicrob Agents Chemother. 1983 Aug;24(2):297-9. doi: 10.1128/AAC.24.2.297.
Abstract
The in vitro activities of new beta-lactam antibiotics was studied and compared with those of other known agents against 51 clinical isolates of Acinetobacter calcoaceticus subsp. anitratus and 23 isolates of A. calcoaceticus subsp. lwoffi. Of the new beta-lactam antibiotics, imipemide (N-formimidoyl thienamycin), ceftazidime, ceftizoxime, ceftriaxone, and piperacillin demonstrated good activities. The minimal inhibitory concentrations for A. calcoaceticus subsp. lwoffi were lower than those obtained for A. calcoaceticus subsp. anitratus.
摘要
研究了新型β-内酰胺类抗生素对51株醋酸钙不动杆菌反硝化亚种和23株醋酸钙不动杆菌鲁氏亚种临床分离株的体外活性，并与其他已知药物进行了比较。在新型β-内酰胺类抗生素中，亚胺培南（N-甲酰亚胺基硫霉素）、头孢他啶、头孢唑肟、头孢曲松和哌拉西林表现出良好的活性。醋酸钙不动杆菌鲁氏亚种的最低抑菌浓度低于醋酸钙不动杆菌反硝化亚种。
相似文献
1
In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.新型β-内酰胺类抗生素对不动杆菌属的体外活性
Antimicrob Agents Chemother. 1983 Aug;24(2):297-9. doi: 10.1128/AAC.24.2.297.
2
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Chemotherapy. 1983;29(5):332-6. doi: 10.1159/000238216.
3
4
Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.341株非发酵革兰阴性菌对七种β-内酰胺类抗生素的敏感性
Eur J Clin Microbiol. 1982 Jun;1(3):159-65. doi: 10.1007/BF02019617.
5
Comparative activities of 13 beta-lactam antibiotics.13种β-内酰胺类抗生素的比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):925-34. doi: 10.1128/AAC.21.6.925.
6
Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.
J Antimicrob Chemother. 1988 Nov;22(5):597-604. doi: 10.1093/jac/22.5.597.
7
Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.环丙沙星与超广谱β-内酰胺类或氨基糖苷类药物对醋酸钙不动杆菌亚种鲍曼不动杆菌的协同相互作用。
Diagn Microbiol Infect Dis. 1988 Apr;9(4):213-7. doi: 10.1016/0732-8893(88)90111-3.
8
In vitro susceptibility of Acinetobacter species to various antimicrobial agents.不动杆菌属对各种抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1986 Nov;30(5):769-70. doi: 10.1128/AAC.30.5.769.
9
[Sensitivity of bacteria of the genus Acinetobacter to antibiotics and ofloxacin].不动杆菌属细菌对抗生素及氧氟沙星的敏感性
Med Dosw Mikrobiol. 1991;43(3-4):103-10.
10
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.新型β-内酰胺类抗生素对囊性纤维化患者铜绿假单胞菌分离株的活性。
Antimicrob Agents Chemother. 1981 Oct;20(4):545-6. doi: 10.1128/AAC.20.4.545.
引用本文的文献
1
Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) .多重耐药（MDR）的毒力潜能及治疗选择
Microorganisms. 2021 Oct 6;9(10):2104. doi: 10.3390/microorganisms9102104.
2
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.巴西库里蒂巴产OXA-23酶的耐碳青霉烯鲍曼不动杆菌暴发。
J Clin Microbiol. 2003 Jul;41(7):3403-6. doi: 10.1128/JCM.41.7.3403-3406.2003.
3
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.不动杆菌属作为医院感染病原菌：微生物学、临床及流行病学特征
Clin Microbiol Rev. 1996 Apr;9(2):148-65. doi: 10.1128/CMR.9.2.148.
4
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
5
Enzymatic profile of clinical isolates of Acinetobacter calcoaceticus.醋酸钙不动杆菌临床分离株的酶谱
Med Microbiol Immunol. 1985;174(1):29-33. doi: 10.1007/BF02123668.
6
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
7
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
8
In vitro susceptibility of Acinetobacter species to various antimicrobial agents.不动杆菌属对各种抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1986 Nov;30(5):769-70. doi: 10.1128/AAC.30.5.769.
9
Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics.庆大霉素耐药和敏感的“鲍曼不动杆菌”对15种替代抗生素的敏感性比较。
Antimicrob Agents Chemother. 1986 Oct;30(4):624-5. doi: 10.1128/AAC.30.4.624.
10
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
本文引用的文献
1
Comparative in vitro study in new cephalosporins.新型头孢菌素的体外比较研究。
Antimicrob Agents Chemother. 1981 Aug;20(2):226-30. doi: 10.1128/AAC.20.2.226.
2
Comparative in vitro study of temocillin (BRL 17421), a new penicillin.新型青霉素替莫西林（BRL 17421）的体外比较研究
Antimicrob Agents Chemother. 1982 Apr;21(4):641-5. doi: 10.1128/AAC.21.4.641.
3
A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.N-甲酰亚胺基硫霉素（MK0787）与其他近期研发的β-内酰胺衍生物抗菌活性的比较。
Antimicrob Agents Chemother. 1982 Aug;22(2):302-7. doi: 10.1128/AAC.22.2.302.
4
The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。
Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.
5
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.阿洛西林、美洛西林和哌拉西林：新型广谱青霉素。
Ann Intern Med. 1982 Nov;97(5):755-60. doi: 10.7326/0003-4819-97-5-755.
6
Mimeae: opportunistic pathogens.A review of infections in a cancer hospital.
JAMA. 1965 Dec 6;194(10):1065-8. doi: 10.1001/jama.194.10.1065.
7
Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.醋酸钙不动杆菌（阴道海雷菌）感染：临床与实验室研究
Medicine (Baltimore). 1977 Mar;56(2):79-97. doi: 10.1097/00005792-197703000-00001.
8
Piperacillin: in vitro evaluation.哌拉西林：体外评估。
Antimicrob Agents Chemother. 1978 Jul;14(1):78-87. doi: 10.1128/AAC.14.1.78.
Zotero 插件